Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 63 
This article has been cited by
1FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma
Yi Zhang,Rong Wang,Xianjin Yang
Medicine.2018;97(51)e13696
[DOI]
2Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation
Hsin-Yeh Chen,Sheng-Nan Lu,Chao-Hung Hung,Jing-Houng Wang,Chien-Hung Chen,Yi-Hao Yen,Yuan-Hung Kuo,Kwong-Ming Kee,Tatsuo Kanda
PLOS ONE.2020;15(11)e0242113
[DOI]
3Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study
Chuanmeng Zhang,Jiayuan Wu,Juan Xu,Jie Xu,Jianchun Xian,Shanshan Xue,Jun Ye
Disease Markers.2019;2019(11)1
[DOI]
4Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
I-Ting Liu,Chia-Sheng Yen,Wen-Lung Wang,Hung-Wen Tsai,Chang-Yao Chu,Ming-Yu Chang,Ya-Fu Hou,Chia-Jui Yen
Cancers.2021;13(21)5323
[DOI]
5Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article
Mohamad Mouchli,Shravani Reddy,Miranda Gerrard,Lisa Boardman,Marrieth Rubio
Annals of Hepatology.2021;22(21)100249
[DOI]
  Search 
  The Journal 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts

Join us